Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Assets (2019 - 2025)

Historic Assets for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $335.1 million.

  • Strata Critical Medical's Assets rose 1842.51% to $335.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.1 million, marking a year-over-year increase of 1842.51%. This contributed to the annual value of $256.7 million for FY2024, which is 1297.32% down from last year.
  • Strata Critical Medical's Assets amounted to $335.1 million in Q3 2025, which was up 1842.51% from $257.9 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Assets registered a high of $346.1 million during Q2 2021, and its lowest value of $250.6 million during Q1 2025.
  • Moreover, its 5-year median value for Assets was $320.2 million (2023), whereas its average is $305.7 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 183843.64% in 2021, then tumbled by 1297.32% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Assets stood at $335.9 million in 2021, then dropped by 3.23% to $325.0 million in 2022, then fell by 9.26% to $294.9 million in 2023, then dropped by 12.97% to $256.7 million in 2024, then skyrocketed by 30.55% to $335.1 million in 2025.
  • Its Assets was $335.1 million in Q3 2025, compared to $257.9 million in Q2 2025 and $250.6 million in Q1 2025.